The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Projection of cancer incidence and death to 2040 in the US: Impact of cancer screening and a changing demographic.
 
Lola Rahib
No Relationships to Disclose
 
Mackenzie Wehner
No Relationships to Disclose
 
Lynn McCormick Matrisian
Other Relationship - Abbvie (Inst); Allergan Foundation (Inst); Amgen Foundation (Inst); AngioDynamics (Inst); AstraZeneca (Inst); Baxter (Inst); Boston Biomedical (Inst); Boston Scientific (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Clovis Oncology (Inst); Elstar Therapeutics (Inst); ERYTECH Pharma (Inst); Genentech (Inst); GlaxoSmithKline (Inst); Halozyme (Inst); Immunovia (Inst); Interpace Diagnostics (Inst); Ipsen (Inst); Janssen Research & Development (Inst); Johnson & Johnson (Inst); Lilly (Inst); Lilly Foundation (Inst); Merck Sharp & Dohme (Inst); Myriad Genetics (Inst); Novartis (Inst); Novartis (Inst); Novocure (Inst); Pfizer (Inst); Rafael Pharmaceuticals (Inst); SERVIER (Inst); Shire (Inst); Takeda (Inst); TriSalus Life Sciences (Inst); TYME (Inst)
 
Kevin Thomas Nead
No Relationships to Disclose